Bafna Pharmaceuticals Limited (BAFNAPH) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.102x

Based on the latest financial reports, Bafna Pharmaceuticals Limited (BAFNAPH) has a cash flow conversion efficiency ratio of 0.102x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs93.12 Million ≈ $1.01 Million USD) by net assets (Rs912.28 Million ≈ $9.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Bafna Pharmaceuticals Limited defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Bafna Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2005–2026)

This chart illustrates how Bafna Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bafna Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bafna Pharmaceuticals Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Abnova Taiwan Corp
TW:4133
0.010x
Infrea AB
ST:INFREA
-0.046x
The Beachbody Company, Inc.
NASDAQ:BODI
-0.038x
BG Staffing Inc
NYSE:BGSF
0.042x
Globetronics Tech Bhd
KLSE:7022
-0.016x
Gold Strike Resources Corp.
V:GSR
-2.876x
Aviation Links Ltd
TA:AVIA
0.028x
German High Street Properties A/S Class B
CO:GERHSP
0.009x

Annual Cash Flow Conversion Efficiency for Bafna Pharmaceuticals Limited (2005–2026)

The table below shows the annual cash flow conversion efficiency of Bafna Pharmaceuticals Limited from 2005 to 2026. For the full company profile with market capitalisation and key ratios, see BAFNAPH market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs1.00 Billion
≈ $10.83 Million
Rs118.27 Million
≈ $1.28 Million
0.118x -48.72%
2025-03-31 Rs848.07 Million
≈ $9.17 Million
Rs195.29 Million
≈ $2.11 Million
0.230x +96.27%
2024-03-31 Rs808.39 Million
≈ $8.74 Million
Rs94.85 Million
≈ $1.03 Million
0.117x +74.02%
2023-03-31 Rs734.55 Million
≈ $7.94 Million
Rs49.52 Million
≈ $535.59K
0.067x -57.06%
2022-03-31 Rs619.64 Million
≈ $6.70 Million
Rs97.28 Million
≈ $1.05 Million
0.157x +165.49%
2021-03-31 Rs567.71 Million
≈ $6.14 Million
Rs-136.09 Million
≈ $-1.47 Million
-0.240x +64.19%
2020-03-31 Rs511.95 Million
≈ $5.54 Million
Rs-342.68 Million
≈ $-3.71 Million
-0.669x -606.06%
2019-03-31 Rs188.52 Million
≈ $2.04 Million
Rs-17.87 Million
≈ $-193.28K
-0.095x +49.95%
2018-03-31 Rs372.02 Million
≈ $4.02 Million
Rs-70.47 Million
≈ $-762.14K
-0.189x -742.20%
2017-03-31 Rs421.12 Million
≈ $4.55 Million
Rs-9.47 Million
≈ $-102.44K
-0.022x -242.15%
2016-03-31 Rs575.71 Million
≈ $6.23 Million
Rs9.11 Million
≈ $98.52K
0.016x -89.21%
2015-03-31 Rs727.13 Million
≈ $7.86 Million
Rs106.65 Million
≈ $1.15 Million
0.147x +536.93%
2014-03-31 Rs697.48 Million
≈ $7.54 Million
Rs16.06 Million
≈ $173.70K
0.023x -95.71%
2013-03-31 Rs683.04 Million
≈ $7.39 Million
Rs366.32 Million
≈ $3.96 Million
0.536x +460.94%
2012-03-31 Rs646.17 Million
≈ $6.99 Million
Rs-96.01 Million
≈ $-1.04 Million
-0.149x -26.74%
2011-03-31 Rs541.89 Million
≈ $5.86 Million
Rs-63.53 Million
≈ $-687.07K
-0.117x -708.49%
2010-03-31 Rs410.05 Million
≈ $4.43 Million
Rs-5.95 Million
≈ $-64.31K
-0.015x +96.00%
2009-03-31 Rs385.23 Million
≈ $4.17 Million
Rs-139.82 Million
≈ $-1.51 Million
-0.363x -105.51%
2008-03-31 Rs118.55 Million
≈ $1.28 Million
Rs-20.94 Million
≈ $-226.43K
-0.177x -115.97%
2007-03-31 Rs91.39 Million
≈ $988.34K
Rs101.06 Million
≈ $1.09 Million
1.106x +1151.53%
2006-03-31 Rs56.78 Million
≈ $614.05K
Rs-5.97 Million
≈ $-64.57K
-0.105x +83.71%
2005-03-31 Rs42.55 Million
≈ $460.13K
Rs-27.46 Million
≈ $-297.02K
-0.646x --

About Bafna Pharmaceuticals Limited

NSE:BAFNAPH India Drug Manufacturers - Specialty & Generic
Market Cap
$39.49 Million
Rs3.65 Billion INR
Market Cap Rank
#22806 Global
#1269 in India
Share Price
Rs154.36
Change (1 day)
-1.55%
52-Week Range
Rs74.50 - Rs193.97
All Time High
Rs507.50
About

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences … Read more